We previously reported that ITD-Flt3 mutations found in ~25–30% of patients with acute myeloid leukemia (AML) and strongly associated with poor prognosis [12–14], increase expression of Survivin. This evidence concerns the gene BIRC5 and acute myeloid leukemia.